Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molclone Labs is an Indian biopharmaceutical company specializing in the development of biosimilars and recombinant proteins. Headquartered in Chennai, the company leverages its expertise in molecular biology and cell line engineering to create high-quality, affordable biologic therapies. Their core capabilities include gene synthesis, vector construction, and the optimization of mammalian and microbial expression systems. Molclone offers a Clone-to-Clinic service model, supporting partners through various stages of bioprocess development and characterization. The company's internal pipeline focuses on major monoclonal antibodies for oncology and autoimmune disorders. By integrating advanced R&D with cost-effective manufacturing strategies, Molclone Labs aims to expand access to essential medicines in emerging and global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molclone Labs.